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ABSTRACT 
Objective: The aim of the study was to conduct an ethnobotanical study focused on the medicinal plants used in Randa (Djibouti) for testing 
pharmacological activities on common microbial diseases.  
Methods: Plant Ratio (PR), Index of Performance (IP) and the high Informant Consensus Factors (ICF) were calculated to select candidate medicinal 
species with a pharmacological potential.  
Results: From this previous work, it was found that the high Informant Consensus Factors, ICF (0.82) for the category of microbial diseases turned 
out to merit further perusal. The findings particularly gave an imminent insight that stimulated additional investigations and analyses. Different 
factors, including Plant Ratio (PR) and Index of Performance (IP) were employed for comparison leading to the selection of 18 candidates species, 
for subsequent pharmacological screening, and testing for antimicrobial activities. Comparison of the information with that accessed from the 
literature implicitly hinted that the Djiboutian traditional medical system shares much in common with other traditional medical systems. At least 
six out of the 18 species have not been pharmacologically tested before. 
Conclusion: The comparison of differents factors (IP2, PR and FL’) of plants screening have showed that 18 plants species of Randa region, have 
good healing potential for infectious diseases. This may inspire continued research to build a comprehensive ethnobotanical and 
ethnopharmacological profiles of the species anticipated to be of the most promising potential for Djibouti and beyond. 
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Many clinically useful prescription drugs have originated from 
traditional medicinal plants. Since there are many traditional 
medicinal plants widely used by the society in Randa (Djibouti), it is 
worth subjecting these plants to investigation for the discovery of 
drugs with an anticipation of obtaining new bioactive substances. 
Randa with its unique climate and vegetation [1] may disclose some 
endemic species which have not been tested previously. 
Poorly developed prevention system and resistance to drugs are the 
two main factors aggravating microbial infections in Djibouti [2-4]. 
This is related to the high prevalence in Djibouti of infectious 
diseases, probably caused by poverty and the general unhygienic 
conditions observed in many parts of Randa region. 
After identifying traditional medicinal plants in Randa (Djibouti) by 
interviewing and conducting discussions with informants, priority 
diseases/disease categories were screened [5, 6]. 
Almost 20% of the medicinal plants recorded were those used by the 
people against infections [1]. This study aims at a selection of 
medicinal plants used for the care of cases of infectious diseases, and 
which have pharmacology properties.
To further strengthen the validity of the present work, a critical 
literature review was made followed by a simple comparison of the 
selected medicinal plants with the previous data gathered from the 
literature. 
  
MATERIALS AND METHODS 
As mentioned previously [1], the ethnobotanical study was 
conducted in Tadjourah District of Randa region in Djibouti, where 
184 informants were interviewed from July 2010 to February 2011.  
In this first study, the Informant Consensus Factor (ICF) was 
calculated for each ailment category to identify the agreements of 
the informants on the reported cures for the group of diseases [7, 8] 
and the Fidelity Level (FL’) Index shows the percentage of 
informants claiming the use of a certain plant for the same ailment. 
We introduced additional statistical analysis for identifying 
candidate plants. 
Plant ratio (PR) 
Plant ratios towards a disease indicating the top ranking plants for a 
given disease, was calculated as PR = (Ip/It) ×100, where Ip is the 
number of informants who independently indicated the use of a 
species for the same ailment and It is the total number of informants 
who mentioned any plant for the same disease. Ratios were rejected 
if Ip (the number of informants) that mentioned any plant for a 
particular disease is less than 15 in order to make certain that plants 
with higher consensus among community members are used for the 
analysis. 
Index of performance (Ip2) [9]  
To illustrate the selectivity of a plant for a specific ailment, a 
comparison was made between the expected and the observed 
values of the proportion of citation of a plant for a specific disease. 
The difference (P1–P2) between the two proportions was then used 
to define an Ip2 performance index which ranged from 0 to 3  
according to an arbitrary scale rationalized for the purpose. The 
calculation P1–P2 was made as follows:  
P1 = C1/C2 
P2 = C3/C4 
C1 = number of citations of a plant A for treating a specific disease B, 
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C2 = number of citations of the same plant A in the global list, 
C3 = total number of citations of the disease B, 
C4 = a total number of citations for all ailments. 
If 0<P1–P2<1/3, therefore Ip2 = 3, which denotes a very low 
performance. 
If 1/3<P1–P2<2/3, therefore Ip2 = 2, which denotes an average 
performance. 
If P1–P2>2/3, therefore Ip2 = 1, which denotes a very high 
performance. 
If P1–P2<0, therefore Ip2 = 0, which denotes no performance. 
The informant consensus factor (ICF)  
The ICF was calculated for each ailment category, to identify the 
agreements of the informants on the reported cures for the group of 
diseases [7, 8]. The Fidelity Level (FL’) Index shows the percentage 
of informants claiming the use of a certain plant for the same ailment 
FL’ ranking was taken into account only if the index of performance 
(Ip2) is ≤ 3. The following scales were adopted for the purpose of 
comparing and prioritizing on the basis of the ranks of the different 
species: If FL’ 0-33, Rank = 3: average performance; FL’34-66, Rank= 
2: high performance; FL’>66, Rank = 1: very high performance. We 
introduced additional statistical analysis for identifying candidate 
plants. 
Preference ranking 
Preference ranking exercise was performed to assess the degree of 
effectiveness of certain medicinal plants against the most prevalent 
diseases in the area. 
The data obtained were summarized through calculations of 
percentages and other values and presented in tables and fig. for 
further analysis and interpretation.  
RESULTS AND DISCUSSION  
Identification of candidate plants by FL’ ranking 
Fidelity Level (FL’) was calculated for each Djiboutian medicinal 
plant. For each microbial ailment, each plant was ranked to find the 
appropriate candidate plant for the ailment. The results obtained are 
summarizing in table 1.  
 
Table 1: FL’ values indicating the top ranking plants for a given disease* 
Scientific names Local names Diseases Category Number of uses IP’ Iu FL’ % Rank 
Ochradenus baccatus Delile malboyta diphteria Microbial 16 16 16 100 100 1 
Acacia tortilis (Forssk.) Hayne eqebto diphteria Microbial 3 3 8 37.5 38 2 
Acacia seyal Delile qadgento dysentery Microbial 12 12 16 75 75 1 
Ziziphus mauritiana Lam. kusra eye infection Microbial 5 5 28 17.8 18 3 
Boscia coriacea Pax. aytinaba jaundice Microbial 4 4 10 40 40 2 
Terminalia brownii Fresen. wayboyta jaundice Microbial 95 95 113 84.1 84 1 
Balanites rotundifolia (Tiegh.) Blatt alayto parasitic worms Microbial 3 3 74 4.0 4 3 
Orthosiphon pallidus Royle ex Benth. abursaafiqi parasitic worms Microbial 6 6 16 37.5 38 2 
Melilotus suaveolens Ledeb. meclab poliomyelitis Microbial 3 3 6 50 50 2 
*(FL’ was taken into account only if IP’≥3. The following scales were adopted for the purpose of comparing and prioritizing on the basis of the ranks 
of the different species: If FL’ 0-33, Rank = 3: average performance; FL’34-66, Rank= 2: high performance; FL’>66, Rank = 1: very high performance). 
Malboyta (Ochradenus baccatus Delile) for diphtheria, Qadgento (Acacia seyal Delile) against dysentery and Wayboyta (Terminalia brownii Fresen.) 
against jaundice are the top species to study according to the fidelity level FL’. 
 
Identification of candidate plants by calculating plant ratios 
The plants that are most interesting for antimicrobial tests are the 
following 3 species, which had 15 or higher mentions of any plant 
and a reasonably good proportion (about half and higher) informant 
consensus [10-14]. 
It can be seen that those diseases that received 15 and above 
mentions of any medicinal plant can be priority species. A few 
species that could be considered in the first priority group include: 
Malboyta (Ochradenus baccatus) with 50% reliability for use against 
diphtheria, Qadgento (Acacia seyal) with 80% reliability against 
dysentery, Wayboyta (Terminalia brownii) with 90% reliability 
against jaundice and Abursaafiqi (Orthosiphon pallidus) with 40% 
reliability against parasites. Likewise, the top three species of each 
category can be identified based on the ranks. Others plants species 
(including those that turned out receiving only one citation) could 
also be checked for their activities as long as resources are available, 
but it is noted that they were backed by minimal number of 
informants, notwithstanding the fact that even a plant mentioned by 
one person only could be effective for the particular disease. In other 
words, those plants with a reasonable number of citations can be 
compared amongst themselves rather than with those that were 
cited by few informants. 
Identification of microbial candidate plants by calculating Index 
performance (IP2) 
The Index of the performance of the microbial infection is presented 
in table 3. Galqaddo (Tarchonanthus camphoratus), Malboyta 
(Ochradenus baccatus) against diphtheria had an IP2 value of 0.97, 
0.73 for Qadgento (Acacia seyal) against dysentery and finally Data-
amqada (Heliotropium longiflorum) for infections. 
Comparison of the different factors 
Plant species that are widely used as remedies for treating microbial 
infections were compared using FL’ (Fidelity Level), IP2 and PR 
ranking; and by judging the combined effectiveness. The species that 
ranked top and selected as priority candidates for testing are shown 
in table 5. Each of the 18 species in table 4, can be considered as 
good enough candidates for pharmacological testing for the diseases 
under which they are listed. 
The FL’
A bibliographical research on the pharmacological properties and 
traditional uses was made [15-106]. The citations number was 
obtained by adding them for every plant. These data allow to define 
the degree of knowledge and to guide possible studies on medicinal 
plants cited in table 5. 
 values of medicinal plants cited by three or more 
informants, for being used against the antimicrobial category 
were compared, and nine of them were selected. These nine 
plant species with high FL’ values also had high PR ratios 
towards a given disease. Among them, the anti-dysentery claim 
for Qadgento (Acacia seyal) deserves special attention in the 
context of increasing the success rate in the search for anti-viral 
drugs. Another interesting finding is the use of Eqebto (Acacia 
tortillis) and Malboyta (Ochradenus baccatus) for diphtheria. 
Other new information found in this analysis is the use of 
Aytinaba (Boscia coriacea) and Wayboyta (Terminilia brownii) as 
anti-jaundice agents. Despite their moderate average rank 3, 11 
others plants species were also selected to be studied. Those 11 
plants had already a selection criterion of 15 for plant ratios and 
were chosen to be included in the study. 
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Table 2: Plant ratios indicating the top ranking plants for a given disease* 
Scientific names Plant Disease Number of 
informants 
(Ip) 
Number of informants 
who mentioned any plant 






Ochradenus baccatus Delile. malboyta diphteria 16 32 50 1 
Acacia tortilis (Forssk.) 
Hayne. 
eqebto 3 32 9 2 
Acalypha fruticosa Forssk. darmuusa 2 32 6 3 
Grewia erythreae Schweinf. cedayto 2 32 6 3 





1 32 3 6 
Ruta chalepensis L. sidaaba 1 32 3 6 
Capparis cartilaginea Decne. xaxaq laynota 1 32 3 6 
Tarchonanthus camphoratus L. galqaddo 1 32 3 6 
Maerua triphylla A. Rich. ruqaysi 1 32 3 6 
Aristolochia bracteolata Lam. suqsuuqi 1 32 3 6 
Acacia seyal Delile. qadgento   12 15 80 1 
Ziziphus mauritiana L. kusra dysentery 2 15 13 2 
Solanum somalense Franch. garbaqaddoyta   1 15 7 3 
Terminalia brownii Fresen. wayboyta   95 105 90 1 
Boscia coriacea Pax. aytinaba   4 105 4 2 
Balanites rotundifolia 
(Tiegh.) Blatt. 
alayto jaundice  2 105 2 4 
Cymbopogon commutatus 
(Steud.) Stapf. 
dambahu   1 105 1 5 
Orthosiphon pallidus Royle 
ex Benth. 
abursaafiqi   6 15 40 1 
Balanites rotundifolia 
(Tiegh.) Blatt. 
alayto   3 15 20 2 
Terminalia brownii Fresen. wayboyta parasite 2 15 13 3 
Buxus hildebrandtii Baill. gaydarto   1 15 7 4 
Ocimum basilicum L. laynoyta   1 15 7 4 
*Ratios are rejected if Ip the number of informants that mentioned any plant for a particular disease is less than 15. 
 
Table 3: Index of performance (IP2) of the plants from randa region within the microbial infection* 
Local 
names 








Capparis cartilaginea Decne. Dipheteria 1 1 2 32 920 0.50 0.03 0.47 2 
Darmuusa Acalypha fruticosa Forssk. Dipheteria 2 0 24 32 920 0.08 0.03 0.05 3 
Eqebto Acacia tortillis (Forssk.) Hayne. Dipheteria 3 3 8 32 920 0.38 0.03 0.34 2 
Galqaddo Tarchonanthus camphoratus L. Dipheteria 1 1 1 32 920 1.00 0.03 0.97 1 
Cedayto Grewia erythraea Schweinf. Dipheterie 2 2 14 32 920 0.14 0.03 0.11 3 
Ruqaysi Maerua triphylla A. Rich. Diphteria 1 1 8 32 920 0.13 0.03 0.09 3 
Sidaaba Ruta chalepensis L. Diphteria 1 1 27 32 920 0.04 0.03 0.00 3 




Indigofera oblongifolia Forssk. Diphtheria 1 1 3 32 920 0.33 0.03 0.30 3 
Malboyta Ochradenus baccatus Delile. Diphtheria 16 16 16 32 920 1.00 0.03 0.97 1 
Meclab Melilotus suaveolens Ledeb. Diphtheria 2 0 6 32 920 0.33 0.03 0.30 3 
Garbaqadd
oyta 
Solanum somalense Franch. Dysentery 1 1 11 15 920 0.09 0.02 0.07 3 
Kusra Ziziphus mauritiana L. Dysentery 2 7 20 15 920 0.10 0.02 0.08 3 
Qadgento Acacia seyal Delile. Dysentery 12 12 16 15 920 0.75 0.02 0.73 1 
Kusra Ziziphus mauritiana L. Eye infection 5 0 28 11 920 0.18 0.01 0.17 3 
Data-
amqada 
Heliotropium longiflorum (A. DC.). 
Jaub and Sapch. 
Infection 1 1 2 8 920 0.50 0.01 0.49 2 
Gaydarceel
a 
Dodonaea angustifolia L. f. Infection 1 1 5 8 920 0.20 0.01 0.19 3 
Kurbeyta Commiphora erythraea (Ehrenb.) 
Engl. 
Infection 1 1 8 8 920 0.13 0.01 0.12 3 
Darmuusa Acalypha fruticosa Forssk. Infection 2 4 24 8 920 0.08 0.01 0.07 3 
Dambahu Cymbopogon commutatus 
(Steud.) 
and Stapf. 
Jaundice 1 1 14 105 920 0.07 0.11 -0.04 0 
Alayto Balanites rotundifolia (Tiegh.) 
Blatt. 
Jaundice 2 6 74 105 920 0.03 0.11 -0.09 0 
Aytinaba Boscia coriacea Pax. Jaundice 4 4 10 105 920 0.40 0.11 0.29 3 
Wayboyta Terminalia brownii Fresen. Jaundice 95 97 11 105 920 0.84 0.11 0.73 1 
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Alayto Balanites rotundifolia (Tiegh.) 
Blatt. 
Malaria 1 0 74 1 920 0.01 0.00 0.01 3 
Abursaafiq
i 
Orthosiphon pallidus Royle ex 
Benth. 
Parasite 6 6 16 15 920 0.38 0.02 0.36 2 
Gaydarto Buxus hidelbrandtii Baill. Parasite 1 1 3 15 920 0.33 0.02 0.32 3 
Laynota Ocimum basilicum L. Parasite 1 1 1 15 920 1.00 0.02 0.98 1 
Alayto Balanites rotundifolia (Tiegh.) 
Blatt. 
Parasite 3 0 74 15 920 0.04 0.02 0.02 3 
Wayboyta Terminalia brownii Fresen. Parasite 2 0 11
3 
15 920 0.02 0.02 0.00 3 
Meclab Melilotus suaveolens Ledeb. Polio 3 5 6 3 920 0.50 0.00 0.50 2 
Qubaabulto Withania somnifera (L.) Dunal. Tuberculosis 1 1 10 4 920 0.10 0.00 0.10 3 
Udda  Balanites aegyptiaca (L.) Delile. Tuberculosis 2 2 7 4 920 0.29 0.00 0.28 3 
Ayrobeya Indigofera articulata Gouan. Tuberculosis  1 1 9 4 920 0.11 0.00 0.11 3 
*If D<0, IP2= 4: below average performance; if 0<D<0.33 IP2=3: average performance; 0.34<D<0.67 IP2 =2, high performance, If D>0.68 IP2 =1, 
very high performance. 
 
Table 4: Important species in their rank order 
Local name of 
disease 
Disease category Local name of plant Scientific name Rank 
FL IP2 ’ PR 
Diphtheria Microbial Infection Malboyta Ochradenus baccatus Delile. 1 1 1 
meclab Melilotus suaveolens Ledeb. ND* 3 3 
eqebto Acacia tortilis (Forssk.) Hayne. 2 2 2 
darmussa Acalypha fruticosa Forssk. ND 3 3 
cedayto Grewia erythraea Schweinf. ND 3 3 
  galqaddo Tarchonanthus camphoratus L. ND 1 ND 
Dysentery Microbial infection Qadgento Acacia seyal Delile. 1 1 1 
kusra Ziziphus mauritiana L. ND 3 2 
garbaqaddoyta Solanum somalense Franch. ND 3 3 
Jaundice Microbial infection Wayboyta Terminalia brownii Fresen. 1 1 1 
aytinaba Boscia coriacea Pax. 2 3 2 
Parasitic worms Microbial infection Wayboyta Terminalia brownii Fresen. ND 3 3 
abursaafiqi Orthosiphon pallidus Royle ex Benth. 2 2 1 
alayto Balanites rotundifolia (Tiegh.) Blatt. 3 3 2 
Malaria Microbial infection Alayto Balanites rotundifolia (Tiegh.) Blatt. ND 3 ND 
Tuberculosis Microbial infection Qubaabulta Withania somnifera (L.) Dunal. ND 3 ND 
udda Balanites aegyptiaca (L.) Delile. ND 3 ND 





Kusra Ziziphus mauritiana L. 1 3 ND 
darmussa Acalypha fruticosa Forssk. ND 3 ND 
gaydarceela Dodonea angustifolia L. f. ND 2 ND 
kurbeyta Commiphora erythraea (Ehrenb.) Engl. ND 3 ND 
Data-amqada Heliotropium longiflorum (A. DC.) Jaub. and 
Spach. 
ND 2 ND 
*ND represents values that were out of the range. 
 
Table 5: Comparison of information on medicinal plant species found in randa region, djibouti with the literature 
Most cited species  Local name Literature found in  




Acacia tortilis (Forssk.) Hayne. eqebto [15-22] [15, 17, 18, 22] 8+4=12 
Acacia seyal Delile. qadgento [23-25] [23, 24, 26-28] 3+5=8 
Terminalia brownie Fresen. wayboyta [29, 30] [31, 30] 2+2=4 
Ochradenus baccatus Delile. malboyta [32-34] [35] 3+1=4 
Boscia coriacea Pax. aytinaba [36] [37-39] 1+3=4 
Melilotus suaveolens Lebed. meclab [40] [41-42] 1+2=3 
Balanites rotundifolia (Tiegh.) Blatt. alayto   [43-44] 0+2=2 
Ziziphus mauritiana L. kusra [45-47, 43, 48] [48-50, 44, 51-54] 5+8=13 
Orthosiphon pallidus Royle ex Benth. abursaafiqi [55] [55] 1+1 
Acalypha fruticosa Forssk. darmussa [56-58] [6,14,37,40,45,54,56, 66] 3+15=18 
Grewia erythraea Schweinf. cedayto [66] [66, 67] 1+2=3 
Solanum somalense Franch. Garbaaqaddoyta [68] [14, 68] 1+2=3 
Withania somnifera (L.) Dunal. Qubaabulto [69-76] [71, 72, 77-79] 8+5=13 
Balanites aegyptiaca (L.) Delile. udda [80-89] [62, 81, 82, 90-95] 10+10=20 
Indigofera articulata Gouan. ayrobeya   0 
Dodonaea angustifolia L. f. gaydarcela [96-98] [96, 99-103] 3+6=9 
Heliotropium longiflorum (A. DC.) Jaub. and Spach. data amqada  [104] 0+1=1 
Comniphora erythraea (Ehrenb.) Engl. kurbeyta [79, 105, 106] [79, 105] 3+2=5 
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CONCLUSION 
By simple comparisons of the different factors (IP2, PR, and FL’) of 
plant screening, 18 plants species were selected to be the most 
potent with good healing results. Most of these recorded plants in 
our study of Randa region of Djibouti were also used in other 
countries where traditional medicine still contributes to healthcare 
services. This indicates the medicinal potential of these plants and 
their ability to have curative properties. Few medicinal plants used 
in Djibouti as having antimicrobial properties were not found in the 
literature. The first selected plants to be further involved in scientific 
studies would be those which have not been tested before against 
bacteria. The list included: Meclab (Melilotus suaveolens), Alayto 
(Balanites rotundifolia), Abursaafiqi (Orthosiphon pallidus), 
Garbaqaddoyta (Solanum somalense), Ayrobeya (Indigofera 
articulata) and Data-amqada (Heliotropium longiflorum). 
Confirmation of the data by simple bioassay analysis and further on 
by isolation of the active principles could lead to templates to the 
synthesis of modern drugs. 
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